DUBLIN--(BUSINESS WIRE)--The "Regulatory Affairs Outsourcing Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.
Regulatory affairs outsourcing is becoming a common practice in the Pharma and Biotech industry. Outsourcing is also practiced in pharmacovigilance as well and most of the companies are looking for partnerships in order to manage the operational tasks which include report publishing and submission as well.
The regulatory affairs outsourcing market is expected to grow at a CAGR of 4.1% to achieve a market size of USD 42 billion in 2024.
Incidences of rising diseases prevalence especially in the regions of Asia Pacific and MEA are driving the growth of the global regulatory affairs outsourcing market in the forecast period. Also, with the advent of new and rare diseases, the number of clinical trials is also increasing, thus leading to an increase in the demand of these services. Furthermore, the growing trend of biosimilars is expected to create a demand for regulatory expertise which will lead to the growth of the regulatory affairs outsourcing market in the forecast period and beyond.
Geographically, the North American region is expected to hold a significant market share due to the highest health expenditure of the United States followed by the Asia Pacific region to be the fastest growing.
This report is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform and geography.
The regulatory affairs outsourcing market has been segmented based on services and geography. Based on services, the market has been segmented into regulatory affairs, clinical trial applications, product registrations, regulatory writing and publishing, regulatory consulting, legal representation, and others.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the regulatory affairs outsourcing market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the regulatory affairs outsourcing market.
Key Topics Covered
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis- Regional Snapshot
4.7. Market Attractiveness
5. REGULATORY AFFAIRS OUTSOURCING MARKET BY SERVICES
5.1. Regulatory Affairs
5.2. Cinical Trial Applications
5.3. Product Registrations
5.4. Regulatory Writing and Publishing
5.5. Regulatory Consulting
5.6. Legal Representation
6. REGULATORY AFFAIRS OUTSOURCING MARKET BY GEOGRAPHY
6.1. North America
6.1.1. United States of America
6.2. South America
6.3.1. United Kingdom
6.4. Middle East and Africa
6.4.2. Saudi Arabia
6.5. Asia Pacific
6.5.4. South Korea
7. COMPETITIVE INTELLIGENCE
7.1. Competitive Benchmarking and Analysis
7.2. Recent Investments and Deals
7.3. Strategies of Key Players
8. COMPANY PROFILES
8.1. Syneos Health
8.3. PRA Health Sciences
8.4. Medpace, Inc.
8.5. Pharmaceutical Product Development, LLC
8.6. Parexel International Corporation
8.7. IQVIA Inc.
8.9. Tech Tammina
8.10. LORENZ Life Sciences Group
For more information about this report visit https://www.researchandmarkets.com/r/x4oc9p